In 2025, the combined sales of Lillys tirzepatide drugs were around $36 billion, outpacing Merck & Co.s oncology drug Keytruda, which has been the best-selling drug since 2023
Afshary K, Chamanara M, Talari B, Rezaei P, Nassireslami E
10-week programme Expert guides and practical tips to support your weight loss journey, available in our freeTracker app
Due to its modified structure, this molecule is often viewed in the market as a specialized research compound with a pronounced growth factor profile
"Phase 3 clinical study: Ipilimumab boosts, sustains immune system responses against melanoma tumors"
Mice were then randomized in five homogenous groups ( n = 5 per group) according to their blood glucose, HOMA-IR and body weight